Literature DB >> 10534121

Coexpression of binding sites for A(B) histo-blood group trisaccharides with galectin-3 and Lag antigen in human Langerhans cells.

K Smetana1, Z Holíková, R Klubal, N V Bovin, B Dvoránková, J Bartůnková, F T Liu, H J Gabius.   

Abstract

Galectin-3 is an immunomodulatory protein with binding capacity for various glycoconjugates including IgE. It has been shown to be produced by epidermal keratinocytes and is present on the surfaces of skin Langerhans cells (LC). Therefore, it may have a role in the pathogenesis of various skin diseases, such as atopic dermatitis. To study the expression of galectin-3 in LC, we used, in addition to specific antibodies, a panel of synthetic, carrier-immobilized, specific oligosaccharides of the A- and B-histo-blood group, which are recognized by this lectin. In the mean time, Birbeck granules were visualized with an anti-Lag antibody. The double labeling experiments showed a remarkable colocalization of signals for Lag antigen (Birbeck granules) and galectin-3, as well as the binding sites for A- and B-histo-blood group trisaccharides. The specificity of the oligosaccharide binding was demonstrated by the lack of binding by Le(c), Le(d) (H blood group antigen), and sLe(x), which are not recognized by galectin-3. These results suggest that galectin-3 is present in Birbeck granules, where it retains reactivity for its glycoligands.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10534121     DOI: 10.1002/jlb.66.4.644

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  7 in total

1.  Analysis of binding of mannosides in relation to Langerin (CD207) in Langerhans cells of normal and transformed epithelia.

Authors:  Jan Plzák; Zuzana Holíková; Barbora Dvoránková; Karel Smetana; Jan Betka; Jana Hercogová; Sem Saeland; Nicolai V Bovin; Hans-Joachim Gabius
Journal:  Histochem J       Date:  2002-05

2.  Detection of galectin-3 in tear fluid at disease states and immunohistochemical and lectin histochemical analysis in human corneal and conjunctival epithelium.

Authors:  E Hrdlicková-Cela; J Plzák; K Smetana; Z Mĕlková; H Kaltner; M Filipec; F T Liu; H J Gabius
Journal:  Br J Ophthalmol       Date:  2001-11       Impact factor: 4.638

3.  Galectin-3: a potential target for cancer prevention.

Authors:  Hafiz Ahmed; Prasun Guha; Engin Kaptan; Gargi Bandyopadhyaya
Journal:  Trends Carbohydr Res       Date:  2011

4.  Diagnostic relevance of Langerin detection in cells from bronchoalveolar lavage of patients with pulmonary Langerhans cell histiocytosis, sarcoidosis and idiopathic pulmonary fibrosis.

Authors:  Karel Smetana; Otakar Mericka; Sem Saeland; Jirí Homolka; Jirí Brabec; Hans-Joachim Gabius
Journal:  Virchows Arch       Date:  2004-01-13       Impact factor: 4.064

Review 5.  IgE and mast cells in allergic disease.

Authors:  Stephen J Galli; Mindy Tsai
Journal:  Nat Med       Date:  2012-05-04       Impact factor: 53.440

Review 6.  Galectin 3: an extraordinary multifunctional protein in dermatology. Current knowledge and perspectives.

Authors:  Efstathia Pasmatzi; Christina Papadionysiou; Alexandra Monastirli; George Badavanis; Dionysios Tsambaos
Journal:  An Bras Dermatol       Date:  2019-07-29       Impact factor: 1.896

Review 7.  Galectin-3 as a Potential Target to Prevent Cancer Metastasis.

Authors:  Hafiz Ahmed; Dina M M AlSadek
Journal:  Clin Med Insights Oncol       Date:  2015-11-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.